Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / W•••••••

T••••••• S••••• Capital Partners Acquires Bioreclamation

Platform acquisitionclosedannounced Apr 25, 2013closed Apr 25, 2013Fact
What happened
Target
W•••••••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
2 named
Buy side
Side not stated
  • W•••••••Targetconfirmed
    “T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that they have acquired W•••••••, New York-based Bioreclamation, a worldwide provider of biological products to life sciences and pharmaceutical companies.”
Evidence
“T••••••• S••••• Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that they have acquired W•••••••, New York-based Bioreclamation, a worldwide provider of biological products to life sciences and pharmaceutical companies.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
T••••••• S••••• Capital Partners Acquires Bioreclamation | Private Equity Intelligence | DFX